Journal of cellular and molecular medicine · 2017
p53 regulates ERK1/2/CREB cascade via a novel SASH1/MAP2K2 crosstalk to induce hyperpigmentation.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhou Ding'an, Kuang Zhongshu, Zeng Xing, Wang Ke, Ma Jiangshu, Luo Huangchao, Chen Mei, Li Yan, Zeng Jiawei, Li Shu, Luan Fujun, He Yong, Dai Hongying, Liu Beizhong, Li Hui, He Lin, Xing Qinghe
Аннотация
We previously reported that three point mutations in SASH1 and mutated SASH1 promote melanocyte migration in dyschromatosis universalis hereditaria (DUH) and a novel p53/POMC/Gαs/SASH1 autoregulatory positive feedback loop is regulated by SASH1 mutations to induce pathological hyperpigmentation phenotype. However, the underlying mechanism of molecular regulation to cause this hyperpigmentation disorder still remains unclear. In this study, we aimed to investigate the molecular mechanism undergirding hyperpigmentation in the dyschromatosis disorder. Our results revealed that SASH1 binds with MAP2K2 and is induced by p53-POMC-MC1R signal cascade to enhance the phosphorylation level of ERK1/2 and CREB. Moreover, increase in phosphorylated ERK1/2 and CREB levels and melanogenesis-specific molecules is induced by mutated SASH1 alleles. Together, our results suggest that a novel SASH1/MAP2K2 crosstalk connects ERK1/2/CREB cascade with p53-POMC-MC1R cascade to cause hyperpigmentation phenotype of DUH.
Предметные рубрики MeSH
Cell Line, TumorCyclic AMP Response Element-Binding ProteinExtracellular Signal-Regulated MAP KinasesHEK293 CellsHumansHyperpigmentationMAP Kinase Kinase 2Models, BiologicalMutationPigmentation DisordersProtein BindingRNA InterferenceSignal TransductionSkin Diseases, GeneticTumor Suppressor Protein p53Tumor Suppressor Proteins